Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMGN

AMGEN Inc.

Sep 18 • 04:00PM ET

332.92

Dollar change +0.12
Percentage change 0.04	%

Healthcare • Drug Manufacturers - General • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	57.36	EPS (ttm)	5.80	Insider Own	0.24%	Shs Outstand	537.33M	Perf Week	0.89%
Market Cap	178.89B	Forward P/E	15.98	EPS next Y	20.84	Insider Trans	-0.16%	Shs Float	536.01M	Perf Month	1.51%
Income	3.13B	PEG	10.25	EPS next Q	5.14	Inst Own	78.22%	Short Float	1.58%	Perf Quarter	8.80%
Sales	30.74B	P/S	5.82	EPS this Y	4.71%	Inst Trans	-1.47%	Short Ratio	4.10	Perf Half Y	22.52%
Book/sh	11.03	P/B	30.18	EPS next Y	6.72%	ROA	3.46%	Short Interest	8.48M	Perf Year	26.51%
Cash/sh	17.31	P/C	19.23	EPS next 5Y	5.60%	ROE	49.27%	52W Range	249.70 - 346.85	Perf YTD	15.59%
Dividend Est.	9.20 (2.76%)	P/FCF	32.64	EPS past 5Y	-0.22%	ROI	4.96%	52W High	-4.02%	Beta	0.61
Dividend TTM	8.88 (2.67%)	Quick Ratio	0.89	Sales past 5Y	3.42%	Gross Margin	63.06%	52W Low	33.33%	ATR (14)	6.61
Dividend Ex-Date	Aug 16, 2024	Current Ratio	1.26	EPS Y/Y TTM	-60.83%	Oper. Margin	21.13%	RSI (14)	55.94	Volatility	1.79% 1.81%
Employees	26700	Debt/Eq	10.57	Sales Y/Y TTM	16.68%	Profit Margin	10.18%	Recom	2.19	Target Price	324.38
Option/Short	Yes / Yes	LT Debt/Eq	9.64	EPS Q/Q	-46.30%	Payout	68.24%	Rel Volume	0.66	Prev Close	332.80
Sales Surprise	0.43%	EPS Surprise	-0.29%	Sales Q/Q	19.90%	Earnings	Aug 06 AMC	Avg Volume	2.07M	Price	332.92
SMA20	1.18%	SMA50	1.30%	SMA200	10.68%	Trades		Volume	1,366,572	Change	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234
Oct-11-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$257 → $279

Show Previous Ratings

Sep-17-24 05:50PM	Amgen (AMGN) Stock Dips While Market Gains: Key Facts (Zacks)
12:40PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Sep-16-24 06:00PM	Amgen (AMGN) Rises Higher Than Market: Key Facts (Zacks)
06:00AM	This 'forgotten child' is one of the best biotech plays: Analyst (Yahoo Finance Video)
10:00AM	Loading…
Sep-13-24 10:00AM	2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500 (Motley Fool)
09:00AM	AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024 (PR Newswire)
Sep-12-24 06:00AM	Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now (Motley Fool)
Sep-11-24 06:32AM	Viridian Therapeutics stock jumps after Phase III trial met all endpoints (Clinical Trials Arena)
Sep-10-24 05:50PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
04:38PM	How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition (Investor's Business Daily)
09:36AM	Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival (Investor's Business Daily)
Sep-09-24 09:00AM	AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024 (PR Newswire)
08:00AM	Amgen Inc: An Exploration into Its Intrinsic Value (GuruFocus.com)
Sep-08-24 01:54AM	Amgen Inc. (AMGN): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
09:00AM	Loading…
Sep-06-24 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
Sep-05-24 11:31AM	Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-04-24 05:50PM	Why the Market Dipped But Amgen (AMGN) Gained Today (Zacks)
Sep-03-24 09:17AM	Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
12:00AM	Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
Aug-30-24 04:00PM	AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE (PR Newswire)
11:12AM	The 10 Pharma Stocks To Watch Including Viking, Roche And Amgen Amid The Fast-Growing Obesity Drug Race (Investor's Business Daily)
Aug-29-24 04:00PM	AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
01:19PM	The 9 Pharma Stocks To Watch Including Viking, Roche And Amgen Amid The Fast-Growing Obesity Drug Race (Investor's Business Daily)
Aug-28-24 02:04PM	Final Trades: Intuit, Amgen, the INDY and URNM (CNBC TV)
Aug-26-24 09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value (GuruFocus.com)
Aug-25-24 06:30PM	3 Unstoppable Dividend Stocks to Buy Right Now (Motley Fool)
Aug-21-24 03:14PM	Pathalys secures $105m to advance SHPT drug through approval (Pharmaceutical Technology)
04:32AM	Amgens Otezla launched for paediatric plaque psoriasis in US (Pharmaceutical Technology)
09:00AM	Loading…
Aug-20-24 09:00AM	OTEZLA (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASIS (PR Newswire)
01:27AM	10 Unhealthiest Countries in Asia (Insider Monkey)
Aug-18-24 05:25AM	2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade (Motley Fool)
Aug-17-24 06:20AM	This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline (Motley Fool)
Aug-15-24 05:30PM	These 10 drugs will be cheaper after Medicare negotiations (Yahoo Finance Video)
04:20PM	US Drug Price Measure to Cut Costs by $7.5 Billion in 2026 (Bloomberg)
10:49AM	Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions. (Yahoo Finance)
07:49AM	Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations (Yahoo Finance)
Aug-14-24 10:31AM	Amgen Inc. (AMGN): Pioneering Healthcare Innovations in Obesity Treatment (Insider Monkey)
Aug-13-24 09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-12-24 08:00AM	Navigating Market Uncertainty: Intrinsic Value of Amgen Inc (GuruFocus.com)
Aug-11-24 08:09AM	What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales (Yahoo Finance)
Aug-10-24 08:18AM	CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 03:33PM	MSD sets sights on bispecific antibody market with Curon acqusition (Pharmaceutical Technology)
01:00PM	How To Earn $100 Per Month From Amgen Stock (Benzinga)
11:55AM	Biotech giant Amgen announces new office in tech-savvy Hyderabad (Investment Monitor)
Aug-08-24 08:43PM	Are Hedge Funds Bullish on Amgen Inc. (AMGN) Now? (Insider Monkey)
Aug-07-24 06:57PM	Amgen Stock Slides on Lowered Guidance (Investopedia) -5.00%
04:10PM	Why Biotech Giant Amgen Stands A Chance Of Taking On Novo, Lilly In Obesity (Investor's Business Daily)
01:52PM	Analyst Report: Amgen Inc. (Morningstar Research)
01:11PM	Why Amgen Stock Is Down Today Despite Solid Q2 Results (Motley Fool)
12:32PM	Midday movers: Super Micro Computer, Airbnb and Lyft fall; Shopify rises (Investing.com)
12:06PM	Amgen, Airbnb fall; Fortinet, Dynatrace rise, Wednesday, 8/7/2024 (Associated Press)
10:22AM	Heard on the Street: It Isnt Time for Novo Nordisk to Worry About Wegovy Yet (The Wall Street Journal)
10:06AM	Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst (Benzinga)
09:55AM	Amgen (AMGN) Stock Down Despite Q2 Earnings & Sales Beat (Zacks)
09:49AM	Stocks to Watch Wednesday: Super Micro, Disney, Rivian, Lyft (The Wall Street Journal)
06:32AM	Amgen reports 45.9% decline in net income to $746m in Q2 2024 (Pharmaceutical Technology)
Aug-06-24 06:45PM	Amgen 'confident' in weight-loss drug MariTide: CFO (Yahoo Finance Video)
06:00PM	Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:31PM	Amgen will continue to see growth regardless of a recession: CFO (Yahoo Finance Video)
05:20PM	Amgen Is Redoubling Its Efforts To Take On Weight-Loss Kingpins Novo, Lilly (Investor's Business Daily)
05:15PM	Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:57PM	Amgen posts mixed Q2 results (Yahoo Finance Video)
04:20PM	Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report (Investor's Business Daily)
04:11PM	Amgen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Amgen quarterly profit slips, obesity data on track for late 2024 (Reuters)
04:01PM	AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
08:39AM	These Stocks Are Moving the Most Today (Barrons.com)
Aug-05-24 05:52PM	Google's search monopoly, El-Erian talks the Fed: Market Domination (Yahoo Finance Video)
05:13PM	Uber earnings, Harris VP announcement: What to Watch (Yahoo Finance Video)
04:59PM	Investing in biotech outside of weight-loss drugs (Yahoo Finance Video)
Aug-04-24 08:00AM	What To Expect in the Markets This Week (Investopedia)
Aug-02-24 05:46PM	Stock Market Slips Into August As Palantir, Disney, Caterpillar Prepare Reports (Investor's Business Daily)
05:09PM	The Most Advanced Country in Biomedical Engineering (Insider Monkey)
05:05PM	Walt Disney earnings, Fedspeak: What to watch (Yahoo Finance Video)
04:00PM	AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND (PR Newswire)
08:00AM	Prediction: This Could Be Amgen's Next Massive Growth Opportunity (Motley Fool)
Aug-01-24 05:50PM	Amgen (AMGN) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	Amgen, Other Dow Jones Companies Highlight Earnings Calendar (Investor's Business Daily)
04:00PM	AMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS (PR Newswire)
09:15AM	Exploring Analyst Estimates for Amgen (AMGN) Q2 Earnings, Beyond Revenue and EPS (Zacks)
Jul-31-24 09:30AM	Can Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings? (Zacks)
Jul-30-24 10:01AM	Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-29-24 03:31PM	Wall Street is still jittery on GLP-1s (Yahoo Finance)
08:00AM	Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc (GuruFocus.com)
07:05AM	NewAmsterdam heart drug hits trial goal, but data appear to disappoint investors (BioPharma Dive)
Jul-26-24 05:50PM	Amgen (AMGN) Advances But Underperforms Market: Key Facts (Zacks)
Jul-25-24 06:00PM	Amgen (AMGN) Stock Moves -0.39%: What You Should Know (Zacks)
03:18PM	Amgen Surges As Weight-Loss Trials Drive Excitement (Investor's Business Daily)
02:26AM	CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now? (Insider Monkey)
Jul-24-24 03:40PM	3 Fabulous Growth Stocks to Buy and Hold Forever (InvestorPlace)
Jul-23-24 02:57PM	7 Biotech Stocks to Keep on Your Clinical Radar (InvestorPlace)
01:23PM	3 Stocks That Are Melting Up. Is There Room to Run? (InvestorPlace)
09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-22-24 04:12AM	Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated (Clinical Trials Arena)
Jul-19-24 05:50PM	Amgen (AMGN) Ascends While Market Falls: Some Facts to Note (Zacks)
07:00AM	Rivals Emerge to Ozempic and Zepboundbut With a Lag (The Wall Street Journal)
Jul-18-24 06:00PM	Amgen (AMGN) Dips More Than Broader Market: What You Should Know (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	May 03 '24	Sale	313.09	2,117	662,802	9,883	May 03 07:48 PM
Grygiel Nancy A.	SVP & CCO	Dec 04 '23	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08 '23	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM
AMGEN INC	10% Owner	Sep 19 '23	Buy	17.00	1,764,705	29,999,985	35,368,653	Sep 19 07:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience